Ardent Health Partners Inc. logo

Ardent Health Partners Inc. (ARDT)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
11. 95
-0.25
-2.0492%
$
1.62B Market Cap
- P/E Ratio
- Div Yield
660,100 Volume
- Eps
$ 12.2
Previous Close
Add Transaction
Day Range
11.95 12.46
Year Range
7.71 15.48
Want to track ARDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ardent Health Passed Its Health Check

Ardent Health Passed Its Health Check

Ardent Health remains a 'buy' as shares are deeply undervalued despite recent profitability declines. ARDT revenue continues to grow, with management projecting $6.4–$6.7 billion for the year, but EBITDA and cash flow are expected to fall short of prior results. Professional fees pressured margins, but management anticipates this cost trend will moderate in the second half, signaling potential stabilization.

Seekingalpha | 2 weeks ago
Is the Options Market Predicting a Spike in Ardent Health Stock?

Is the Options Market Predicting a Spike in Ardent Health Stock?

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Zacks | 1 month ago
Implied Volatility Surging for Ardent Health Stock Options

Implied Volatility Surging for Ardent Health Stock Options

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Zacks | 2 months ago
New Strong Sell Stocks for August 7th

New Strong Sell Stocks for August 7th

ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.

Zacks | 2 months ago
Ardent Health Q2 Earnings Call Highlights

Ardent Health Q2 Earnings Call Highlights

Ardent Health NYSE: ARDT reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes.

Marketbeat | 2 months ago
Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates

Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates

Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.52 per share a year ago.

Zacks | 2 months ago
Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?

Ardent Health, Inc. (ARDT) Expected to Beat Earnings Estimates: Should You Buy?

Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Do Options Traders Know Something About Ardent Health Stock We Don't?

Do Options Traders Know Something About Ardent Health Stock We Don't?

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Zacks | 3 months ago
Ardent Health, Inc. (ARDT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Ardent Health, Inc. (ARDT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Ardent Health, Inc. (ARDT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seekingalpha | 4 months ago
Ardent Health, Inc. (ARDT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Ardent Health, Inc. (ARDT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Ardent Health, Inc. (ARDT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago
Ardent Health, Inc. (ARDT) Q1 2026 Earnings Call Transcript

Ardent Health, Inc. (ARDT) Q1 2026 Earnings Call Transcript

Ardent Health, Inc. (ARDT) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
Loading...
Load More